Updates on AHPA activities and resources delivered to your inbox. Subscribe today!
The November 2021 AHPA Report includes: AHPA Webinar: AERs and Product Recalls, AHPA updates Proposition 65 hemp industry guidance following passage of California AB 45, AHPA expresses support for lawful marketing of NAC ; and more!
The American Herbal Products Association (AHPA) provided a letter of support to the World Anti-Doping Agency (WADA) following the September 14, 2021 announcement of WADA’s Executive Committee recommendation that a scientific review of cannabis (Cannabis sativa L.) will be undertaken by the agency in 2022.
In this issue of the IADSA Newsflash:The Indian Food Safety and Standards Authority has published draft regulation named Ayurveda Aahar, based on the tradition of Ayurveda foods.; The European Commission is consulting on a draft Regulation restricting the use of green tea catechins in food supplements; The European Commission has ordered a mass recall of products contaminated with ethylene oxide; and more!
The American Herbal Products Association (AHPA) on October 8, 2021, joined the Natural Products Association (NPA) and the Council for Responsible Nutrition (CRN) in calling on the Food and Drug Administration (FDA) to clarify that N-acetyl cysteine (NAC) is a lawful dietary ingredient.
AHPA has published an update to its Guidance on California Proposition 65 and Hemp Products to recognize the impact of the passage of California AB 45 Industrial hemp products, which was signed into law by Governor Gavin Newsome on October 6, 2021.
The United States District Court for the Southern District of New York last week entered summary judgment in favor of the United States Food and Drug Administration (FDA) in a suit filed in 2017 that sought to overturn FDA’s allowance for the GRAS self-affirmation process commonly used to document the safety of new food ingredients.
The Food and Drug Administration (FDA) has called on the U.S. Congress to pass legislation that would require mandatory product listing (MPL) for all dietary supplements in the United States.
The October 2021 AHPA Report includes: AHPA Immune Supplements Congress Preview; AHPA Webinar: From DNA Barcoding to COVID-19: State Attorneys General and Supplement Enforcement; AHPA 2021 Fall Committee & Event Schedule; and more!
American Herbal Products Association (AHPA) Chief Information Analyst Merle Zimmermann, Ph.D., attended the 158th Cosmetic Ingredient Review (CIR) Expert Panel Meeting for Cosmetic Ingredient Safety held virtually from Washington, D.C., September 13-14.
AHPA has published Spanish language versions of educational resources that finished product marketers and botanical ingredient companies can provide to their supply chains to help educate farm managers and workers about best practices for avoidance of pyrrolizidine alkaloid (PA) contamination.